TriSalus Life Sciences In... (TLSI)

5.50

-0.02 (-0.36%)

At close: Apr 01, 2025, 3:59 PM

5.54

0.76%

After-hours: Apr 01, 2025, 04:01 PM EDT

TriSalus Life Sciences Cash Flow Statement

Chart Mode

Year	FY23	FY22	FY21	FY20
Net Income	-59.04M	-47.19M	-28.84M	-711.39K
Depreciation & Amortization	702K	398K	464K	321K
Stock-Based Compensation	1.4M	368K	109K	22K
Other Working Capital	953K	-2.57M	-1.84M	-569.98K
Other Non-Cash Items	6.15M	11.5M	6.54M	603.77K
Deferred Income Tax	n/a	310K	-832K	n/a
Change in Working Capital	740K	2.3M	-131K	-569.98K
Operating Cash Flow	-50.05M	-32.31M	-22.7M	-677.6K
Capital Expenditures	-1.12M	-786K	-1.26M	-545K
Acquisitions	n/a	-1M	-1M	n/a
Purchase of Investments	n/a	n/a	n/a	-250M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	-1.53M	-1M	-1M	-9.16M
Investing Cash Flow	-2.12M	-1.79M	-2.26M	-250M
Debt Repayment	-87K	-131K	-1.3M	-178.08K
Common Stock Repurchased	-20K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	45.53M	94K	54K	n/a
Financial Cash Flow	54.63M	13.46M	50.77M	252.01M
Net Cash Flow	2.46M	-20.64M	25.81M	-3.63M
Free Cash Flow	-51.17M	-33.1M	-23.95M	-1.22M